Related Experiment Videos
Cefprozil
1Division of Pediatric Infectious Disease, Memorial Miller Children's Hospital, Long Beach, California 90801-1428.
Abstract:
Cefprozil is a new, orally bioavailable, cephalosporin with significant activity against the bacteria commonly associated with upper and lower respiratory tract infection, and skin and soft tissue infections. Its absorption and elimination dynamics suggest once- or twice-daily dosing. The low-rate of gastrointestinal and dermatologic side effects associated with cefprozil administration suggest that it may have a significant role in the management of patients with these infections. Children with pharyngitis or urinary tract infection are more appropriately treated with antibiotics having a narrower spectrum of activity. With a variety of newer cephalosporins being marketed in the early 1990s, it will be important for the clinician to examine the data from ongoing comparative clinical trials to determine which antibiotic is best for a patient with a specific infection and whether the added cost justifies its use.
Insights
Cefprozil, an oral cephalosporin, shows effectiveness against common respiratory and skin infections, suggesting convenient dosing. However, narrower-spectrum antibiotics may be better for pediatric pharyngitis or UTIs.
Area of Science:
- Pharmacology and Infectious Diseases
- Clinical Microbiology
Background:
- Cefprozil is an orally bioavailable cephalosporin antibiotic.
- It exhibits activity against bacteria implicated in common infections.
Purpose of the Study:
- To evaluate the efficacy and dosing potential of cefprozil.
- To assess its safety profile for respiratory and skin infections.
Main Methods:
- Clinical trials data analysis (implied).
- Pharmacokinetic and pharmacodynamic evaluation.
- Adverse event monitoring.
Main Results:
- Cefprozil demonstrates significant activity against common respiratory and skin pathogens.
- Absorption and elimination kinetics support once- or twice-daily dosing regimens.
- Low incidence of gastrointestinal and dermatologic side effects observed.
Conclusions:
- Cefprozil may be a valuable option for managing respiratory and skin infections.
- Consideration of narrower-spectrum antibiotics is recommended for pediatric pharyngitis and UTIs.
- Comparative trials are essential to guide optimal cephalosporin selection and cost-effectiveness.